Pharmaceuticals company Blue Jet Healthcare announced Q2FY26 results Revenue from Operations: Rs 1,655 million compared to Rs 2,083 million during Q2FY25, change -20.5%. EBITDA: Rs 549 million compared to Rs 695 million during Q2FY25, change -20.9%. EBITDA Margin: 33.2% for Q2FY26. PBT: Rs 687 million compared to Rs 769 million during Q2FY25, change -10.7%. PAT: Rs 521 million compared to Rs 583 million during Q2FY25, change -10.6%. PAT Margin: 31.5% for Q2FY26. Result PDF